FDA fast tracks ADHD drug centanafadine, targeting approval by July 24 for treatment across all age groups, based on phase 3 trial results.
Sun Pharmaceutical Industries has launched a nationwide recall of ADHD medication pills after laboratory tests revealed the capsules failed to dissolve properly, raising concerns for thousands of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results